Goldman Sachs Group Inc Stereotaxis, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 193,124 shares of STXS stock, worth $426,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193,124
Previous 111,980
72.46%
Holding current value
$426,804
Previous $237,000
148.95%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STXS
# of Institutions
112Shares Held
43MCall Options Held
13.8KPut Options Held
31.4K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...